MAXCYTE, INC. LONG-TERM INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT FOR US PERSONSNon-Statutory Stock Option Agreement • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
EIGHTH AMENDMENT TO LEASE AGREEMENTLease Agreement • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
THIS EIGHTH AMENDMENT TO LEASE AGREEMENT (“this Eighth Amendment”) is made as of September 27, 2019 (“Eighth Amendment Effective Date”), by and between ARE-20/22/1300 FIRSTFIELD QUINCE ORCHARD, LLC, a Delaware limited liability company, having an address at 385 E Colorado Boulevard, Suite 299, Pasadena, California 91101 (“Landlord”), and MAXCYTE, INC., a Delaware corporation, having an address at 22 Firstfield Road, Suite 110, Gaithersburg, Maryland 20878 (“Tenant”).
FIRST AMENDMENT TO SUBLEASESublease • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
This First Amendment to Sublease (“First Amendment”) is entered into as of the 9th day of September, 2019, by and between NOVAVAX, INC., a Delaware corporation (“Sublandlord”), and MAXCYTE, INC., a Delaware corporation (“Subtenant”).
FIRST AMENDMENT TO SUBLEASESublease • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
This First Amendment to Sublease (“First Amendment”) is entered into as of the 9th day of September, 2019, by and between NOVAVAX, INC., a Delaware corporation (“Sublandlord”), and MAXCYTE, INC., a Delaware corporation (“Subtenant”).
SUBLEASESublease • June 25th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research
This Sublease (“Sublease”) is made as of the 9th day of September, 2019 (the “Effective Date”), by and between Novavax, Inc., a Delaware corporation (“Sublandlord”), and MaxCyte, Inc., a Delaware corporation (“Subtenant”).
